Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
50.31 USD | +0.30% | +0.42% | -30.08% |
12-07 | Global markets live: AbbVie, McDonald's, Apple, AMD, Alphabet... | ![]() |
12-07 | Are rate cuts are coming early next year? | ![]() |
Sales 2023 * | 44.79B 60.85B | Sales 2024 * | 45.9B 62.36B | Capitalization | 102B 139B |
---|---|---|---|---|---|
Net income 2023 * | 7.96B 10.82B | Net income 2024 * | 7.29B 9.9B | EV / Sales 2023 * | 2,84x |
Net Debt 2023 * | 24.94B 33.88B | Net Debt 2024 * | 16.87B 22.92B | EV / Sales 2024 * | 2,60x |
P/E ratio 2023 * | 13,3x | P/E ratio 2024 * | 12,6x | Employees | 34,300 |
Yield 2023 * | 4,53% | Yield 2024 * | 4,74% | Free-Float | 69.53% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
1 day | +0.30% | ||
1 week | +0.42% | ||
Current month | +1.88% | ||
1 month | -4.03% | ||
3 months | -17.28% | ||
6 months | -22.97% | ||
Current year | -30.08% |
1 week
49.56
51.00

1 month
48.25
51.74

Current year
48.25
75.18

1 year
48.25
79.36

3 years
48.25
81.44

5 years
42.48
81.44

10 years
42.48
81.44

Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 2015 | |
Giovanni Caforio
CHM | Chairman | 58 | 1999 |
David Elkins
DFI | Director of Finance/CFO | 54 | 2019 |
Members of the board | Title | Age | Since |
---|---|---|---|
Phyllis R. Yale
BRD | Director/Board Member | 65 | 2019 |
Peter Arduini
BRD | Director/Board Member | 58 | 2016 |
Derica Rice
BRD | Director/Board Member | 58 | 2020 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
12.97% | 323 M€ | -8.82% | - | |
6.42% | 18 M€ | -7.62% | - | |
6.03% | 16 M€ | 0.00% | - | |
5.00% | 820 M€ | -4.99% | - |
Date | Price | Change | Volume |
---|---|---|---|
23-12-08 | 50.31 | +0.30% | 10,123,073 |
23-12-07 | 50.16 | +0.56% | 14,710,574 |
23-12-06 | 49.88 | -0.70% | 13,839,803 |
23-12-05 | 50.23 | +0.50% | 12,659,509 |
23-12-04 | 49.98 | -0.24% | 14,238,572 |
Delayed Quote Nyse, December 08, 2023 at 04:00 pm
More quotesSector
Pharmaceuticals
Calendar
Trading Rating :
Investor Rating :
ESG Refinitiv :
B
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
50.31USD
Average target price
64.13USD
Spread / Average Target
+27.48%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.08% | 102 B $ | |
+63.47% | 538 B $ | |
+42.56% | 430 B $ | |
-12.58% | 372 B $ | |
-7.63% | 264 B $ | |
-6.49% | 263 B $ | |
-12.81% | 232 B $ | |
+1.35% | 198 B $ | |
-9.77% | 197 B $ | |
-43.83% | 163 B $ |

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition